123 related articles for article (PubMed ID: 15638270)
1. Cyclooxygenase-2 expression in canine appendicular osteosarcomas.
Mullins MN; Lana SE; Dernell WS; Ogilvie GK; Withrow SJ; Ehrhart EJ
J Vet Intern Med; 2004; 18(6):859-65. PubMed ID: 15638270
[TBL] [Abstract][Full Text] [Related]
2. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
[TBL] [Abstract][Full Text] [Related]
5. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
6. Clinical and pathologic relevance of p53 index in canine osseous tumors.
Loukopoulos P; Thornton JR; Robinson WF
Vet Pathol; 2003 May; 40(3):237-48. PubMed ID: 12724563
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
8. Glucose transporter 1 expression in canine osteosarcoma.
Petty JC; Lana SE; Thamm DH; Charles JB; Bachand AM; Bush JM; Ehrhart EJ
Vet Comp Oncol; 2008 Jun; 6(2):133-40. PubMed ID: 19178673
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-11 receptor alpha is expressed on canine osteosarcoma.
Sottnik JL; Thamm DH
Vet Comp Oncol; 2010 Jun; 8(2):96-102. PubMed ID: 20579322
[TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
Kleiter M; Malarkey DE; Ruslander DE; Thrall DE
Vet Radiol Ultrasound; 2004; 45(3):255-60. PubMed ID: 15200266
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
Wolfesberger B; Walter I; Hoelzl C; Thalhammer JG; Egerbacher M
Res Vet Sci; 2006 Jun; 80(3):308-16. PubMed ID: 16182328
[TBL] [Abstract][Full Text] [Related]
12. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.
Mohammed SI; Khan KN; Sellers RS; Hayek MG; DeNicola DB; Wu L; Bonney PL; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):479-83. PubMed ID: 15062852
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.
Selvarajah GT; Verheije MH; Kik M; Slob A; Rottier PJ; Mol JA; Kirpensteijn J
Vet J; 2012 Aug; 193(2):412-9. PubMed ID: 22436430
[TBL] [Abstract][Full Text] [Related]
14. Distribution and activity levels of matrix metalloproteinase 2 and 9 in canine and feline osteosarcoma.
Gebhard C; Fuchs-Baumgartinger A; Razzazi-Fazeli E; Miller I; Walter I
Can J Vet Res; 2016 Jan; 80(1):66-73. PubMed ID: 26733734
[TBL] [Abstract][Full Text] [Related]
15. p53 tumor suppressor protein overexpression in osteogenic tumors of dogs.
Sagartz JE; Bodley WL; Gamblin RM; Couto CG; Tierney LA; Capen CC
Vet Pathol; 1996 Mar; 33(2):213-21. PubMed ID: 8801715
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of clinical and histopathologic prognostic factors for survival in canine osteosarcoma of the extracranial flat and irregular bones.
Kruse MA; Holmes ES; Balko JA; Fernandez S; Brown DC; Goldschmidt MH
Vet Pathol; 2013 Jul; 50(4):704-8. PubMed ID: 23269349
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs.
McEntee MF; Cates JM; Neilsen N
Vet Pathol; 2002 Jul; 39(4):428-36. PubMed ID: 12126145
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of 5-lipoxygenase expression in canine osteosarcoma and the effects of a dual 5-lipoxygenase/cyclooxygenase inhibitor on osteosarcoma cells in vitro and in vivo.
Goupil RC; Bushey JJ; Peters-Kennedy J; Wakshlag JJ
Vet Pathol; 2012 Sep; 49(5):802-10. PubMed ID: 22287649
[TBL] [Abstract][Full Text] [Related]
20. Investigating CXCR4 expression in canine appendicular osteosarcoma.
Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
